日本語View as Markdown

Hemodialysis employing molecular hydrogen (H) enriched dialysis solution may improve dialysis related fatigue through impact on energy metabolism.

水素富化透析液を用いた血液透析が透析関連疲労とエネルギー代謝に与える影響

human observational study injection / infusion positive

Abstract

Hemodialysis using electrolysis-generated hydrogen-enriched dialysate (E-HD) has been associated with reduced dialysis-related fatigue, yet its relationship to metabolic changes remained poorly understood. A total of 81 patients on standard hemodialysis were categorized into three groups based on fatigue severity and activity impact, then followed for 12 months after switching to E-HD. Patients with fatigue accompanied by activity reduction showed significant fatigue improvement, along with reductions in body fat and gains in skeletal muscle mass despite stable body weight. Enrichment analysis identified baseline differences in fatty acid metabolism, the citric acid cycle, and glycolysis between the highest-fatigue and no-fatigue groups; these metabolic disparities diminished following E-HD. The findings suggest that E-HD may reduce dialysis-related fatigue partly through modulation of energy metabolic pathways in uremic patients.

Mechanism

E-HD may alleviate dialysis-related fatigue by normalizing disrupted energy metabolism pathways—including fatty acid oxidation, the citric acid cycle, and glycolysis—observed in fatigued uremic patients at baseline.

Bibliographic

Authors
Nakayama M, Watanabe K, Sato E, Ito Y, Kadota N, Konishi K, et al.
Journal
Sci Rep
Year
2025 (2025-02-11)
PMID
39934143
DOI
10.1038/s41598-025-88827-2
PMC
PMC11814270

Tags

Disease:運動・疲労回復 腎疾患 Delivery:点滴投与 Mechanism:ミトコンドリア 酸化ストレス

Delivery context

Intravenous hydrogen-saline infusion is a clinic-only route and is not viable for everyday self-administration. For routine hydrogen intake, inhalation is the most practical route, but inhalation carries explosion risk and concentration matters (empirical LFL of 10%; high-concentration 66% / 100% devices are not recommended).

Safety notes

Intravenous hydrogen-saline infusion is a clinic-only route and is not viable for everyday self-administration. For routine hydrogen intake, inhalation is the most practical route, but inhalation carries explosion risk and concentration matters (empirical LFL of 10%; high-concentration 66% / 100% devices are not recommended).

See also:

Other papers on the same disease / condition

Cite as: H2 Papers — PMID 39934143. https://h2-papers.org/en/papers/39934143
Source: PubMed PMID 39934143